CatalystEarnings

$WST. WEST PHARMACEUTICAL SERVICES

WST

$406.99

-0.22%

What changed

FQ3 FY2026 (ends Sep) | reported Oct 29: - Revenue: $874M - Adj EPS: $2.66 vs $2.20 🟢 - GAAP op margin: 30.6% (📈 +9.7pp YoY) Guidance (company): - FQ4 (ends Dec) revenue: $820M-$835M

Why it matters

FQ3 FY2026 (ends Sep) | reported Oct 29:

Sources

sec